Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06362304
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-12
First Post:
2024-04-09
Brief Title:
99mTc-CNDG SPECTCT in Brain Tumors
Sponsor:
Peking Union Medical College Hospital
Organization:
Peking Union Medical College Hospital
Study Overview
Official Title:
Application of 99mTc-CNDG SPECTCT Imaging in the Diagnosis of Brain Tumors
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to evaluate the value of 99mTc-CNDG for diagnosis of brain tumors by comparing it with 18F-FDG-PET The main questions it aims to answer are
1 What is the diagnostic consistency between 99mTc-CNDG and 18F-FDG
2 What is the correlation between the SUVmax value of 99mTc-CNDG and tumor type
Participants will
Receive18F-FDG-PET and 99mTc-CNDG examination within 2 weeks before surgery Obtain pathological diagnosis by surgery or biopsy as the gold standard
1 What is the diagnostic consistency between 99mTc-CNDG and 18F-FDG
2 What is the correlation between the SUVmax value of 99mTc-CNDG and tumor type
Participants will
Receive18F-FDG-PET and 99mTc-CNDG examination within 2 weeks before surgery Obtain pathological diagnosis by surgery or biopsy as the gold standard
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None